USPTO serial 79218842
Serial No. 79218842
Reviewed by CopyMark Law Group
Reg. 5547884Status 707Registered
- Filing date
- Status date
- Registration date
- Aug 28, 2018
- Examiner
- YI, CRYSTAL HAEIN
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with Serial No. 79218842?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christina M. Licursi
Christina M. Licursi Wolf, Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic preparations and reagents for scientific or research use; chemical reagents for non-medical purposes; reagents for in vitro use in biochemistry, clinical chemistry, science and research; chemical preparations, namely, [ buffer solutions and ] reagents for scientific or research use with laboratory apparatus, namely, separation apparatus [ and analysis apparatus; biomarkers, namely, nucleic acids, proteins and other biochemical ligands for scientific or research use; ] chemical test kits for clinical research or medical laboratory use in the detection of cancer and other clinical disorders and diseases, and diagnostic kits comprised of diagnostic reagents and assay components for scientific, research, clinical and medical laboratory use | ACTIVE | — |
| 005 | [ Medical diagnostic reagents and assay components for testing body fluids, namely, blood and plasma, and cells, all for clinical and medical use; medical diagnostic kits comprised of medical diagnostic reagents and assay components for testing of body fluids, namely, blood and plasma, and cells, for the presence of cancer and other medical disorders for medical purposes and non-pharmaceutical companion medical diagnostics purposes, all the aforesaid goods excluding any such goods that are prescription only pharmaceuticals ] | SECTION 71 - CANCELLED | — |
| 009 | Apparatus, equipment and instruments for scientific, laboratory, non-medical diagnostic or general research use, namely, laboratory analyzers for measuring, testing, and analyzing bodily fluids, blood, plasma, cells, and tissue, pre-packed columns for use in separation and purification, glassware, and tubes in the nature of laboratory storage tubes, namely, sample tubes, reagent tubes, [ phlebotomy tubes and plastic tubes; ] apparatus, equipment and instruments for cytology, histology and for use in detecting medical diseases and disorders, not for medical use, and all for laboratory use, non-medical diagnostic or general research use; apparatus in the nature of cassettes for harvesting rare cells for use in laboratory, diagnostic or general research use; laboratory apparatus, namely, cell analyser for providing quantitative cell analysis for scientific, laboratory or general research use and disposable cassettes for harvesting rare cells therefor; apparatus and equipment for use in testing and analysing tissue, blood, cells and plasma not for medical use, and all for laboratory use, diagnostic or general research use; [ diagnostic reagent kits not for medical use and all for laboratory use consisting primarily of medical diagnostic reagents and assays for use in detecting cancerous conditions and other conditions involving somatic genetic changes; biological analysis computer software; ] structural parts and fitting for the aforesaid goods | ACTIVE | — |
| 010 | Medical diagnostic apparatus, equipment and instruments for laboratory analysis and clinical diagnosis of human diseases; medical diagnostic testing apparatus, equipment and instruments for testing in the field of cancer; medical testing kits consisting primarily of medical diagnostic apparatus for testing body fluids, namely, blood and plasma, and rare cells for use in detecting cancerous conditions; structural parts and fittings for the aforesaid goods, namely, medical diagnostic apparatus, equipment and instruments for cytology, histology, and for use in detecting cancer | ACTIVE | — |
| 042 | Biological, [ scientific ] and medical research and consultation services related thereto; [ product research and development in the fields of biology and medical sciences; custom development of biochemical reagents; ] services of a chemical laboratory; medical research laboratory services, in particular in the fields of diagnostics and development of tests for clinical diagnosis and the detection of medical conditions and disorders; advice and information relating to the aforesaid services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Angle Europe Limited
- Other trademarks owned by Angle Europe Limited
- Other trademarks owned by Angle Europe Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 7, 2026 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Apr 9, 2026 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Apr 9, 2026 | INPC | INVALIDATION PROCESSED | — |
| Nov 28, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 12, 2025 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 12, 2025 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Feb 12, 2025 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| Feb 11, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 22, 2024 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Aug 28, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Apr 2, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 28, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 11, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 11, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 28, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 28, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 23, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jun 15, 2018 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jun 12, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 12, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 23, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 23, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 23, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 8, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 3, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 3, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 3, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 3, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 27, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 26, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 26, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 25, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 25, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 17, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 1, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 1, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 28, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 25, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 24, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 24, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 24, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 24, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 19, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |